Tracked vehiclesAnduril Enterprise 0.87% fill $173.4M / $20BCBP AST 46.50% fill $929.9M / $2.0BPalantir Maven 81.60% fill $637.6M / $781.3MShield AI USCG $61.4M drawn 12 ordersCounter-drone $2.1B drawn 25 C-UAS vehicles and awardsUSAspending compile · Oct 9 2026
AwardTape

AwardTape · Defense awards · Medical · Diagnostics and lab supplies · FA301625F0224

FA301625F0224: $15K delivery order to Microgenics Corporation

Microgenics Corporation holds a delivery order from Department of the Air Force with $15K obligated since Oct 2023, against a ceiling of $15K. Latest action Jun 13, 2025.

Purchasing amps reagent kits for the afdtl NAVY contract n0018925dz006all the terms and conditions applies to this order.

PIIDFA301625F0224
Typedelivery order
Parent awardN0018925DZ006
CompanyMicrogenics Corporation
AgencyDepartment of the Air Force
Contracting officeFA3016 502 CONS CL
CategoryMedical · Diagnostics and lab supplies
PSC6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Obligated since Oct 2023$15K
Total obligated (lifetime)$15K
Ceiling (base and all options)$15K
Base dateJun 13, 2025
Latest actionJun 13, 2025
End dateSep 16, 2025
Actions since Oct 20231
PricingFirm fixed price
CompetitionCompeted under simplified acquisition
Place of performanceTX
SourceUSAspending.gov record
Reporting lagDoD 90 days
About this record

Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.

Terminal: alerts on new orders and modifications to this contract, and CSV export.

7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.

Start free trial